Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

WNT/β-catenin regulatory roles on PD-(L)1 and immunotherapy responses
Keywan Mortezaee
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

lncRNA CHAF1B-2 contributes to the tumorigenesis of gastric cancer by activating the Wnt/β-catenin pathway
Shaoqi Tian, Junjie Shen, Dao-Ping Sun, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Why Is Wnt/β-Catenin Not Yet Targeted in Routine Cancer Care?
Auriane de Pellegars-Malhortie, Laurence Picque Lasorsa, Thibault Mazard, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 949-949
Open Access | Times Cited: 2
Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
Wiebke Werner, Maria Kuzminskaya, Isabella Lurje, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 159-179
Open Access | Times Cited: 1
Targeting the Wnt/β-catenin signal pathway for the treatment of gastrointestinal cancer: Potential for advancement
Xizhi Jin, Sijie Wang, Lihua Luo, et al.
Biochemical Pharmacology (2024) Vol. 227, pp. 116463-116463
Closed Access | Times Cited: 1
Belling the “cat”: Wnt/β-catenin signaling and its significance in future cancer therapies
Atul Kumar Goyal, Satyajit Laxman Murkute, Sujoy Bhowmik, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189195-189195
Closed Access | Times Cited: 1
Synergistic Combination of Oral Transcytotic Nanomedicine and Histone Demethylase Inhibitor for Enhanced Cancer Chemoimmunotherapy
Jing Zhang, Qiuyu Wei, Ying Piao, et al.
ACS Nano (2024)
Closed Access | Times Cited: 1
Assessment of the circulating levels of immune system checkpoint selected biomarkers in patients with lung cancer
Banafsheh Safizadeh, Maryam Sadeh, Ali Karami Robati, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access
Predictive value of ZFHX4 mutation for the efficacy of immune checkpoint inhibitors in non-small cell lung cancer and melanoma
C. D. Fu, Haoran Gu, Lin Sun, et al.
Investigational New Drugs (2024)
Closed Access
Traditional Chinese medicine and its components effectively reduce resistance mediated by immune checkpoint inhibitors
Mingxin Guo, Wentong Fang, Zhiqiang Hu
Frontiers in Immunology (2024) Vol. 15
Open Access
SMURF1 leads to the β-catenin signaling-mediated progression of esophageal squamous carcinoma by losing PATZ1-induced CCNG2 transcription
Lingling Chen, Jie Tang, Yunli Chang, et al.
Biochemical Pharmacology (2024), pp. 116688-116688
Closed Access
lncRNA CHAF1B-2 contributes to the tumorigenesis of gastric cancer via activating the Wnt/β-catenin pathway
Shaoqi Tian, Junjie Shen, Dao-Ping Sun, et al.
Research Square (Research Square) (2024)
Closed Access
Page 1

Scroll to top